Annual report pursuant to Section 13 and 15(d)

Organization and Business (Details)

v3.20.4
Organization and Business (Details)
2 Months Ended 12 Months Ended
Jan. 22, 2021
USD ($)
Jan. 19, 2021
USD ($)
Jul. 27, 2020
USD ($)
Jun. 08, 2020
USD ($)
Mar. 20, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 15, 2019
USD ($)
Jun. 20, 2019
USD ($)
Apr. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
patent
machineProfile
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Jan. 07, 2021
shares
Jan. 06, 2021
shares
Dec. 16, 2020
$ / shares
shares
Dec. 15, 2020
shares
Oct. 07, 2020
shares
Oct. 06, 2020
shares
May 31, 2020
USD ($)
Apr. 10, 2020
USD ($)
Nov. 01, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]                                        
Number of machine profiles in database | machineProfile                   500,000,000                    
Number of issued patents | patent                   18                    
Number of pending patents | patent                   7                    
Debt Instrument [Line Items]                                        
Intangible assets acquired                   $ 0 $ 2,575,000                  
Net cash used in operating activities                   5,599,335 5,338,383                  
Net loss                   7,304,569 4,488,107                  
Decrease in accounts payable                   2,271,578 1,978,974                  
Increase (decrease) in accounts receivable                   (1,317,508) 973,522                  
Increase in accrued expenses and other liabilities                   $ 623,576 $ 1,348,033                  
PPP loan                                     $ 1,100,000  
Consideration received on transaction     $ 10,750,000 $ 5,500,000 $ 688,000       $ 1,500,000                      
Common stock shares authorized (in shares) | shares                   100,000,000 100,000,000     150,000,000 100,000,000 100,000,000 60,000,000      
Common stock, par value (in usd per share) | $ / shares                   $ 0.001 $ 0.001     $ 0.001            
Subsequent Event                                        
Debt Instrument [Line Items]                                        
Consideration received on transaction $ 6,250,000 $ 8,000,000                                    
Common stock shares authorized (in shares) | shares                       150,000,000 100,000,000              
COVID-19                                        
Debt Instrument [Line Items]                                        
Employee salaries in excess causing a percentage of salary forgone                                   $ 100,000    
Line of Credit                                        
Debt Instrument [Line Items]                                        
Stated interest rate                                       10.00%
Terminated Merger with Conversion Point Technologies                                        
Debt Instrument [Line Items]                                        
Termination fee               $ 2,800,000                        
Terminated Merger with Conversion Point Technologies | Conversion Point Holdings Inc                                        
Debt Instrument [Line Items]                                        
Face amount               36,000,000                        
Indebtedness Satisfaction Amount                                        
Debt Instrument [Line Items]                                        
Accrued principal and interest outstanding               1,063,288                        
Termination fee               1,063,288                        
ReTargeter Satisfaction Amount                                        
Debt Instrument [Line Items]                                        
Termination fee               1,611,712                        
Intangible assets acquired               $ 2,570,000                        
Litigation Fee                                        
Debt Instrument [Line Items]                                        
Termination fee           $ 250,000 $ 125,000